Biomarkers for advancing diagnosis and prognosis in stroke - PubMed

5 hours ago

Biomarkers are needed to improve stroke diagnosis, prognosis, and personalized medicine.
Current clinical algorithms lack precision in diagnosing stroke before hospital admission, predicting disease progression, and assessing recurrence risk.
An international panel of stroke experts identified 17 research priorities and five minimum reporting datasets for stroke biomarker studies.
Key domains for biomarker research include prehospital diagnosis, ischemic stroke progression, atrial cardiopathy, plaque vulnerability, and intracerebral hemorrhage.
The proposed framework aims to promote consistency and collaboration in biomarker discovery, validation, and clinical translation.
Many authors disclosed conflicts of interest, including grants, consulting fees, and advisory roles with pharmaceutical companies.

Hasty Briefsbeta